Joseph Gligorov is currently Professor of Medical Oncology at Sorbonne University and Medical Practitioner at Medical Oncology Department of Tenon Hospital, Paris (APHP). He is also part of the INSERM team U938 “Cancers Biology and Treatments”. He is actually the executive director of the Institut Universitaire de Cancerologie APHP.6 – Sorbonne University.
Pr Gligorov’s major clinical and translational research interests are breast cancer and the investigation of factors that predict patient response to anticancer treatment.
Professor Gligorov is also in charge of Nice - St Paul de Vence conference for breast cancer treatment guidelines, and member of diﬀerent national working groups devoted to cancer treatment strategies. He is also co-founder and president of the Mediterranean Association for Radiotherapy Oncology and Medical Oncology (AROMe) devoted to cancer patients care improvement, access to innovations and oncology education in emerging countries around Mediterranean area.
He is a member of several editorial boards, advisory committees and national and international scientiﬁc societies. He is also ESMO and ESO core faculty member and is one of the members of the ESO-ESMO Metastatic Breast Cancer Task Force.
Pr Joseph Gligorov as published more than 300 journal articles (among them more than half medline indexed) and participated in the editing and writing of several books.